Therapeutic goals for behavioral intervention among hypertensive subjects at high vs. low risk for cardiovascular disease

被引：0
|
作者：
Nolan, R. P.
Barry-Bianchi, S. M.
Mechetiuc, A. E.
Grace, S. L.
Stewart, D. E.
机构：
[1] Univ Hlth Network, Toronto, ON, Canada
[2] Univ Toronto, Toronto, ON, Canada
[3] York Univ, Toronto, ON M3J 2R7, Canada
来源：
JOURNAL OF HYPERTENSION | 2006年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：S173 / S173
页数：1
相关论文
共 50 条
  • [21] Low vs. Higher-Dose Dark Chocolate and Blood Pressure in Cardiovascular High-Risk Patients
    Desch, Steffen
    Kobler, Daniela
    Schmidt, Johanna
    Sonnabend, Melanie
    Adams, Volker
    Sareban, Mandi
    Eitel, Ingo
    Blueher, Matthias
    Schuler, Gerhard
    Thiele, Holger
    AMERICAN JOURNAL OF HYPERTENSION, 2010, 23 (06) : 694 - 700
  • [22] Epidemiology of conventional cardiovascular risk factors among hypertensive subjects with normal and impaired fasting glucose
    Akintunde, A. A.
    SAMJ SOUTH AFRICAN MEDICAL JOURNAL, 2010, 100 (09): : 594 - 597
  • [23] Impact of telmisartan on cardiovascular outcome in hypertensive patients at high risk: a Telmisartan Randomised AssessmeNt Study in ACE iNtolerant subjects with cardiovascular Disease subanalysis
    Foulquier, Sebastien
    Boehm, Michael
    Schmieder, Roland
    Sleight, Peter
    Teo, Koon
    Yusuf, Salim
    Schumacher, Helmut
    Unger, Thomas
    JOURNAL OF HYPERTENSION, 2014, 32 (06) : 1334 - 1341
  • [24] Health risk appraisal only vs. targeted disease management for worksite cardiovascular risk reduction
    Maron, DJ
    Forbes, BL
    Groves, JR
    Dietrich, MS
    Sells, P
    DiGenio, AG
    CIRCULATION, 2005, 111 (14) : E210 - E211
  • [25] Nutraceuticals for Serum Lipid and Blood Pressure Control in Hypertensive and Hypercholesterolemic Subjects at Low Cardiovascular Risk
    Alberto Mazza
    Salvatore Lenti
    Laura Schiavon
    Marco Zuin
    Maria D’Avino
    Emilio Ramazzina
    Edoardo Casiglia
    Advances in Therapy, 2015, 32 : 680 - 690
  • [26] Nutraceuticals for Serum Lipid and Blood Pressure Control in Hypertensive and Hypercholesterolemic Subjects at Low Cardiovascular Risk
    Mazza, Alberto
    Lenti, Salvatore
    Schiavon, Laura
    Zuin, Marco
    D'Avino, Maria
    Ramazzina, Emilio
    Casiglia, Edoardo
    ADVANCES IN THERAPY, 2015, 32 (07) : 680 - 690
  • [27] Effectiveness of a Lifestyle Intervention Program Among Persons at High Risk for Cardiovascular Disease and Diabetes in a Rural Community
    Vadheim, Liane M.
    Brewer, Kari A.
    Kassner, Darcy R.
    Vanderwood, Karl K.
    Hall, Taryn O.
    Butcher, Marcene K.
    Helgerson, Steven D.
    Harwell, Todd S.
    JOURNAL OF RURAL HEALTH, 2010, 26 (03): : 266 - 272
  • [28] Effects of a multifaceted intervention on GPs on the cardiovascular risk factors of high risk hypertensive patients in primary prevention
    Pouchain, D.
    Huas, D.
    Lebeau, J. P.
    Boutitie, F.
    Lievre, M.
    Girerd, X.
    Bruckert, E.
    Chapman, J.
    EUROPEAN HEART JOURNAL, 2011, 32 : 972 - 972
  • [29] Prevalence and clinical characteristics of hypertensive patients with high vs low risk of osas
    Brostroem, A.
    Stahlkrantz, A.
    Albers, J.
    Nystrom, F.
    Sunnergren, O.
    Ulander, M.
    Svanborg, E.
    SLEEP, 2008, 31 : A196 - A197
  • [30] Increased cardiovascular risk in subjects with a low prevalence of classic cardiovascular risk factors: The inflammatory bowel disease paradox
    Zanoli, Luca
    Inserra, Gaetano
    Castellino, Pietro
    TRENDS IN CARDIOVASCULAR MEDICINE, 2015, 25 (08) : 705 - 706
12345